PMID- 28409271 OWN - NLM STAT- MEDLINE DCOM- 20180712 LR - 20211204 IS - 1573-2665 (Electronic) IS - 0141-8955 (Linking) VI - 40 IP - 5 DP - 2017 Sep TI - Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency. PG - 745-747 LID - 10.1007/s10545-017-0036-4 [doi] AB - Clinical finding of cutis laxa, characterized by wrinkled, redundant, sagging, nonelastic skin, is of growing significance due to its occurrence in several different inborn errors of metabolism (IEM). Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade. Here, we further expand the list of inborn errors of metabolism associated with cutis laxa by describing the clinical presentation of a 17-month-old girl with Leigh-like syndrome due to enoyl coenzyme A hydratase, short chain, 1, mitochondria (ECHS1) deficiency, a mitochondrial matrix enzyme that catalyzes the second step of the beta-oxidation spiral of fatty acids and plays an important role in amino acid catabolism, particularly valine. FAU - Balasubramaniam, S AU - Balasubramaniam S AD - Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia. shanti.balasubramaniam@health.nsw.gov.au. AD - Genetic Metabolic Disorders Service, Western Sydney Genetics Program, The Children's Hospital at Westmead, Cnr Hawkerbusry Rd and Hainworth St, Locked Bag 4001, Westmead, 2145, NSW, Australia. shanti.balasubramaniam@health.nsw.gov.au. AD - Discipline of Genetic Medicine, Sydney Medical School, University of Sydney, Sydney, NSW, 2145, Australia. shanti.balasubramaniam@health.nsw.gov.au. AD - Discipline of Paediatrics & Child Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. shanti.balasubramaniam@health.nsw.gov.au. FAU - Riley, L G AU - Riley LG AD - Discipline of Paediatrics & Child Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. AD - Genetic Metabolic Disorders Research Unit, The Children's Hospital at Westmead, KRI, Sydney, NSW, 2145, Australia. FAU - Bratkovic, D AU - Bratkovic D AD - Metabolic Unit, SA Pathology, Women's and Children's Hospital, North Adelaide, 5006, SA, Australia. FAU - Ketteridge, D AU - Ketteridge D AD - Metabolic Unit, SA Pathology, Women's and Children's Hospital, North Adelaide, 5006, SA, Australia. FAU - Manton, N AU - Manton N AD - Department of Surgical Pathology, SA Pathology, Women's and Children's Hospital, North Adelaide, 5006, SA, Australia. FAU - Cowley, M J AU - Cowley MJ AD - Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. FAU - Gayevskiy, V AU - Gayevskiy V AD - Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. FAU - Roscioli, T AU - Roscioli T AD - Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. AD - St Vincent's Clinical School, University of New South Wales, Sydney, NSW, 2010, Australia. AD - Department of Medical Genetics, Sydney Children's Hospital, Randwick, Australia. FAU - Mohamed, M AU - Mohamed M AD - Institute for Genetic and Metabolic Disease, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands. AD - Department of Pediatrics, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands. FAU - Gardeitchik, T AU - Gardeitchik T AD - Institute for Genetic and Metabolic Disease, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands. AD - Department of Pediatrics, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands. FAU - Morava, E AU - Morava E AD - Institute for Genetic and Metabolic Disease, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands. AD - Hayward Genetics Center, Tulane University Medical Center, New Orleans, LA, USA. FAU - Christodoulou, J AU - Christodoulou J AD - Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia. AD - Discipline of Genetic Medicine, Sydney Medical School, University of Sydney, Sydney, NSW, 2145, Australia. AD - Discipline of Paediatrics & Child Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. AD - Genetic Metabolic Disorders Research Unit, The Children's Hospital at Westmead, KRI, Sydney, NSW, 2145, Australia. AD - Murdoch Children's Research Institute and Victorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, VIC, Australia. AD - Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia. LA - eng GR - 1026891/NHMRC project grant/ GR - 017.008.052/Netherlands Organisation for Scientific Research/ PT - Case Reports PT - Journal Article DEP - 20170413 PL - United States TA - J Inherit Metab Dis JT - Journal of inherited metabolic disease JID - 7910918 RN - 0 (MAS1 protein, human) RN - 0 (Proto-Oncogene Mas) RN - EC 4.2.1.17 (ECHS1 protein, human) RN - EC 4.2.1.17 (Enoyl-CoA Hydratase) SB - IM MH - Cutis Laxa/*genetics MH - Enoyl-CoA Hydratase/*deficiency MH - Female MH - Humans MH - Infant MH - Leigh Disease/*genetics MH - Proto-Oncogene Mas OTO - NOTNLM OT - Compound Heterozygous Variant OT - Cutis Laxa OT - Mitochondrial Matrix Enzyme OT - Respiratory Chain Enzyme Activity OT - Transaldolase EDAT- 2017/04/15 06:00 MHDA- 2018/07/13 06:00 CRDT- 2017/04/15 06:00 PHST- 2017/01/10 00:00 [received] PHST- 2017/03/06 00:00 [accepted] PHST- 2017/02/25 00:00 [revised] PHST- 2017/04/15 06:00 [pubmed] PHST- 2018/07/13 06:00 [medline] PHST- 2017/04/15 06:00 [entrez] AID - 10.1007/s10545-017-0036-4 [pii] AID - 10.1007/s10545-017-0036-4 [doi] PST - ppublish SO - J Inherit Metab Dis. 2017 Sep;40(5):745-747. doi: 10.1007/s10545-017-0036-4. Epub 2017 Apr 13.